Scholars Central

Conference abstractPublished 24 Feb 2020

Characterization of adverse effects and it's associations in the patient medicated with anti-tubercular drugs

Authors: Priyatam Khadka

Tribhuvan University Teaching Hospital, Nepal

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Adverse effects from long-term therapeutic intervention in tuberculosis are obvious. However, were taken nonchalantly due to the only therapeutic alternative. Objective: The objective of this study was to characterize the adverse effects and it’s associations in the patient medicated with anti-tubercular drugs. Methods: A longitudinal prospective study was conducted among the patient medicated with anti-tubercular drugs. As per the guideline of Nepal’s National Tuberculosis Control Program me (NTP), Nepal, the treatment category was selected, fixed-dose-regimen was calculated, and treatment outcome was affirmed. Patients’ demographics and other clinical details were extracted from the repository files. Upon a consecutive follow-up, observed adverse effects were noted and multivariate logistic analysis against independent factors was done for elucidating any association. Result: Of 177 cases enrolled, 138(77.9%) reported at least two adverse effects. In our multivariate logistic analysis: female, abnormal Body Mass Index (BMI) i.e. underweight and overweight cases, patients’ behaviors i.e. smoking/ drinking or both clinical diagnosed cases and intensive treatment phase were independently associated with adverse side effects. Loss of appetite (85.4%) was the commonest while dermatologic manifestations (1.2%) and severe weightloss (1.2%) were the least observed side-effects among the patient medicated with anti-tubercular drugs. Absolute drug-induced-toxicity was observed in treatment failure or MDR (Multi-Drug-Resistant) subjects. Conclusion: Adverse effects from anti-tubercular therapy are associated with patients’ demographics variables. Symptomatic treatment, regular follow-up after implicated therapy, and therapeutic-discontinuation may be required for successful outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Infectious Diseases & Preventive Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Preventive Medicine
  • SubjectInfectious Diseases
  • SubjectPublic Health & Epidemiology
  • BylineArticles whose byline prints “Priyatam Khadka”